Skip to main content
. 2014 Feb 7;8(1):75–84. doi: 10.4161/pri.27776

Table 1. Predicted aggregation behavior of cancer and neurodegenerative proteins.

Method
Protein
Aggrescan Tango Waltz Zyggregator
Mouse PrP nHS: 3
NnHS: 1.435
nHS: 1
Agg: 61.2177
nHS: 4 Zagg: 0.998
Ztox: 0.107975
Human p53 nHS: 8
NnHS: 2.036
NHS: 2
Agg: 761.196
nHS: 1 Zagg: 0.909
Ztox: -1.51057
Human p63 nHS: 10
NnHS: 1.767
* nHS: 3 Zagg: 0.709
Ztox: -1.51621
Human p73 nHS: 9
NnHS: 1.804
* nHS: 5 Zagg: 0.842
Ztox: -0.904242
Aβ 1–42 nHS: 2
NnHS: 4.762
NHS: 2
Agg: 1598.46
nHS: 2 Zagg: 0.975
Ztox: 0.504339
α-synuclein nHS: 6
NnHS: 4.286
NHS: 4
Agg: 896.077
nHS: 1 Zagg: 0.980
Ztox: -0.829966
SOD1 nHS: 6
NnHS: 3.896
NHS: 1
Agg: 145.586
nHS: 1 Zagg: 0.862
Ztox: -0.136983

AGGRESCAN predicts aggregation-prone segments. WALTZ predicts amyloid-forming sequences. ZYGGREGATOR predicts different phases of the aggregation process. nHS: number of Hot Spots. NnHS, Normalized nHS for 100 residues; Agg, the propensity for β-sheet aggregation; Zagg, the tendency to convert from the unfolded state to the amyloid state; Ztox, the tendency to convert from the unfolded state to oligomeric assemblies. Zagg and Ztox values close to 1 represent a high aggregation propensity. WALTZ was performed with Best Overall Performance threshold. Conditions were as follows: pH 7.0, 298.15 kelvin and 0.02 M (ionic strength). *TANGO limits analysis to 500 amino acids.